Texas Oncology - Paris — Fort Worth, Texas

Public research footprint of Texas Oncology - Paris, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Non-small Cell Lung Cancer · Chronic Lymphocytic Leukemia · Metastatic Breast Cancer

Recently updated registry entries

NCT06161025 — A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade… (Recruiting)
NCT07218341 — A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic… (Recruiting)
NCT02488967 — Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Texas Oncology - Paris?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.